Valuation : Convatec Group PLC

Market Cap 5.76B 4.95B 4.67B 4.26B 7.96B 551B 8.03B 55.65B 21.42B 279B 21.62B 21.15B 887B P/E 2026 *
22.9x
P/E 2027 * 15.9x
Enterprise Value 7.14B 6.14B 5.8B 5.28B 9.87B 683B 9.96B 69.05B 26.57B 346B 26.83B 26.24B 1,101B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.55x
Free-Float
95.14%
Yield 2026 *
2.7%
Yield 2027 * 3.08%
1 day-1.48%
1 week-4.17%
Current month-1.65%
1 month-5.68%
3 months+10.39%
6 months-7.97%
Current year-8.57%
1 week 11.85
Extreme 11.854
12.16
1 month 11.85
Extreme 11.854
13.03
Current year 10.45
Extreme 10.45
14.09
1 year 10.45
Extreme 10.45
14.09
3 years 9.9
Extreme 9.9
16.65
5 years 8.69
Extreme 8.69
16.65
10 years 0
Extreme 0
18.52
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-4.17% - - 5.76B
-1.78%-4.99%-20.10%+2.61% 179B
-0.29%-1.59%-0.76%+14.58% 117B
-0.73%-4.82%+8.31%+80.61% 61.25B
-1.92%-6.01%+8.80%+41.11% 50.24B
-1.88%-5.97%-6.37%-33.87% 48.05B
+0.75%-5.80%+11.20%-19.01% 31.89B
-4.88%-11.48% - - 28.42B
+2.17%+0.44%+34.88%-12.44% 24.23B
+0.49%-7.65%-12.44%+4.86% 21.4B
Average -1.03%-5.18%+2.94%+9.81% 62.39B
Weighted average by Cap. -1.30%-4.24%-3.94%+12.66%

Financials

2026 *2027 *
Net sales 2.56B 2.2B 2.07B 1.89B 3.53B 244B 3.56B 24.7B 9.51B 124B 9.6B 9.39B 394B 2.73B 2.35B 2.22B 2.02B 3.78B 261B 3.81B 26.41B 10.17B 133B 10.26B 10.04B 421B
Net income 248M 213M 201M 184M 343M 23.73B 346M 2.4B 923M 12.04B 932M 912M 38.24B 360M 309M 292M 266M 497M 34.39B 502M 3.48B 1.34B 17.44B 1.35B 1.32B 55.4B
Net Debt 1.39B 1.19B 1.12B 1.02B 1.92B 133B 1.93B 13.4B 5.16B 67.23B 5.21B 5.09B 214B 1.21B 1.04B 981M 893M 1.67B 116B 1.69B 11.68B 4.5B 58.61B 4.54B 4.44B 186B
Logo Convatec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
10/09/26 US$11.95 -1.48% 3,859
09/09/26 US$12.13 -0.25% 11,819
08/09/26 US$12.16 -3.49% 12,539
04/09/26 US$12.60 +1.04% 7,906
03/09/26 US$12.47 -1.89% 16,232
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.946USD
Average target price
4.054USD
Spread / Average Target
+37.61%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!